Bio-Rad Laboratories Inc (BIO)
Debt-to-equity ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total stockholders’ equity | US$ in thousands | 6,569,300 | 7,487,860 | 6,778,790 | 9,051,130 | 8,741,130 | 8,416,200 | 8,446,890 | 9,763,720 | 9,615,250 | 8,453,600 | 8,922,600 | 10,182,900 | 13,667,100 | 15,332,400 | 11,594,900 | 10,609,100 | 9,879,940 | 8,825,140 | 7,353,400 | 6,293,080 |
| Debt-to-equity ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-equity ratio = Long-term debt ÷ Total stockholders’ equity
= $—K ÷ $6,569,300K
= 0.00
Bio-Rad Laboratories Inc has consistently maintained a debt-to-equity ratio of 0.00 across multiple quarters from March 31, 2020, to December 31, 2024. This indicates that the company has either no debt or very minimal debt in relation to its equity. A debt-to-equity ratio of 0.00 typically signifies a low financial risk and a strong financial position, as it suggests that the company relies more on equity financing rather than debt to fund its operations and growth. Overall, Bio-Rad Laboratories Inc's stable and low debt-to-equity ratio reflects a conservative financial strategy and prudent management of its capital structure.
Peer comparison
Dec 31, 2024